Alex Goglia
@alexgoglia
PGY4 @MSKCancerCenter, @MSK_RadOnc. Holman Research Pathway Resident in @RossLevineLab. MD/PhD from @RWJMS + @Princeton.
ID: 25841927
https://scholar.google.com/citations?user=pM1Bx50AAAAJ&hl=en 22-03-2009 16:53:20
3,3K Tweet
1,1K Followers
2,2K Following
Couldn’t make it to ASTRO this year due to a conflict, but please go see Alex Goglia, Memorial Sloan Kettering Radiation Oncology Holman Resident PGY5, present our work today on outcomes for prostate spinal metastases treated with SBRT in CNS 3 from 12:45-2pm.
Elevated clonal hematopoiesis in 9/11 first responders has distinct age-related patterns and relies on IL1RAP for clonal expansion aacrjournals.org/cancerdiscover… Amit Verma Uli Steidl
Prospective phase II trial of short-course androgen deprivation, pelvic SBRT, and brachytherapy boost for NCCN high-risk #ProstateCancer with low-intermediate-risk #Decipher genomic score. Presented by Alex Goglia Memorial Sloan Kettering Cancer Center. #ASTRO25 written coverage by Zach Klaassen
Seeing this in real time at VUMC where 1 in 5 cath lab patients have CHIP. We're building care pathways but standardization across centers would help. Curious what others are doing for longitudinal follow-up. Michael Raddatz Pradeep Natarajan Alex Bick
This is not the usual phylogenetic tree of somatic mutations showing what clonal expansions are present and when they arose in a tissue. It additionally shows which cells within the tissue are affected and how the mutations change those cells. Congrats Dan Landau! Lovely work!
Launching the Cleveland Clinic CHIP Cardiology Clinic, an exciting step toward integrating clonal hematopoiesis into cardiovascular care. Excited to share my Circulation paper with Dr. Peter Libby, outlining our vision for the growth and development of CHIP Cardiology programs
Dr. Ross Levine (Ross Levine), Senior Vice President of Translational Research at MSK, has been named MSK's new Chief Scientific Officer (CSO). Dr. Levine will be responsible for setting and leading strategy for basic and translational research, including programs, centers,
An intriguing study from Shelley Herbrich & Pam Sharma MD Anderson Cancer Center published in Cancer Cell TET2-mutant clonal hematopoiesis enhances macrophage antigen presentation and improves immune checkpoint therapy in solid tumors cell.com/cancer-cell/fu… Making lemonade out of CH lemons!
